Emilio Paredes-Galán
Research Subjects
Emilio Paredes-Galán has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Rodríguez-Pascual
Department of Geriatric Medicine, Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
8 shared publications - Arturo Vilches-Moraga
University of Manchester
5 shared publications - Francisco Calvo-Iglesias
Servicio de Cardiología, Hospital Universitario Álvaro Cunqueiro, Vigo, Pontevedra, Spain
5 shared publications Andrés Íñiguez-Romo
4 shared publicationsFernando Rodríguez-Artalejo
Department of Preventive Medicine and Public Health, Universidad Autónoma de Madrid /IdiPaz, CIBERESP, and IMDEA-Food Institute, Madrid, Spain
3 shared publicationsMarta Torrente-Carballido
3 shared publications
Latest Publications
- Open Access
- 1 January 2019
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 12 (1) , 22-32
Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement
- 1 January 2019
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 12 (1) , 22-32
Open AccessAssessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement
- 1 November 2018
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 19 (11) , 936-941
Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study
- 1 November 2018
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 19 (11) , 936-941
Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Oldest Old Patients: A Prospective Study
- Open Access
- 1 March 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 37 (3) , 239-245
Effect of beta-blocker dose on mortality after acute coronary syndrome
- 1 March 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia (English Edition)
- Vol. 37 (3) , 239-245
Open AccessEffect of beta-blocker dose on mortality after acute coronary syndrome
- Open Access
- 1 March 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 37 (3) , 239-245
Effect of beta-blocker dose on mortality after acute coronary syndrome
- 1 March 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 37 (3) , 239-245
Open AccessEffect of beta-blocker dose on mortality after acute coronary syndrome
- 1 December 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 224, 125-131
The frailty syndrome and mortality among very old patients with symptomatic severe aortic stenosis under different treatments
- 1 December 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 224, 125-131
The frailty syndrome and mortality among very old patients with symptomatic severe aortic stenosis under different treatments
- Open Access
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 8 (1) , 81-8
Pulmonary vein stenosis: Etiology, diagnosis and management
Pulmonary vein stenosis (PVS) is rare condition characterized by a challenging diagnosis and unfavorable prognosis at advance stages. At present, injury from radiofrequency ablation for atrial fibrillation has become the main cause of the disease. PVS is characterized by a progressive lumen size reduction of one or more pulmonary veins that, when hemodynamically significant, may raise lobar capillary pressure leading to signs and symptoms such as shortness of breath, cough, and hemoptysis. Image techniques (transesophageal echocardiography, computed tomography, magnetic resonance and perfusion imaging) are essential to reach a final diagnosis and decide an appropriate therapy. In this regard, series from referral centers have shown that surgical and transcatheter interventions may improve prognosis. The purpose of this article is to review the etiology, assessment and management of PVS.
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Cardiology
- Vol. 8 (1) , 81-8
Open AccessPulmonary vein stenosis: Etiology, diagnosis and management
Pulmonary vein stenosis (PVS) is rare condition characterized by a challenging diagnosis and unfavorable prognosis at advance stages. At present, injury from radiofrequency ablation for atrial fibrillation has become the main cause of the disease. PVS is characterized by a progressive lumen size reduction of one or more pulmonary veins that, when hemodynamically significant, may raise lobar capillary pressure leading to signs and symptoms such as shortness of breath, cough, and hemoptysis. Image techniques (transesophageal echocardiography, computed tomography, magnetic resonance and perfusion imaging) are essential to reach a final diagnosis and decide an appropriate therapy. In this regard, series from referral centers have shown that surgical and transcatheter interventions may improve prognosis. The purpose of this article is to review the etiology, assessment and management of PVS.
- 1 June 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-6
Defining requirements for an atrial fibrillation screening system that implements tele-holtering on a cloudified infrastructure
This work intends to define requirements to design, deploy, evaluate and validate the feasibility, efficiency and safety of an enriched telecardiology application for providing remotely ECG and Holter diagnostic/monitor services as atrial fibrillation screening. The platform must include supporting tools for e-learning that allow to operate the solution by general practitioners and patients for second opinion, best follow-up through home monitoring and on-line learning, boosted by an on-demand virtualized data recording and training infrastructure, based on a cloudified infrastructure. It can be understood as an experiment that will use a cloudified infrastructure to deploy new telecardiology related services, particularly for atrial fibrillation patients that could be monitorized from several ambulatories.
- 1 June 2015
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-6
Defining requirements for an atrial fibrillation screening system that implements tele-holtering on a cloudified infrastructure
This work intends to define requirements to design, deploy, evaluate and validate the feasibility, efficiency and safety of an enriched telecardiology application for providing remotely ECG and Holter diagnostic/monitor services as atrial fibrillation screening. The platform must include supporting tools for e-learning that allow to operate the solution by general practitioners and patients for second opinion, best follow-up through home monitoring and on-line learning, boosted by an on-demand virtualized data recording and training infrastructure, based on a cloudified infrastructure. It can be understood as an experiment that will use a cloudified infrastructure to deploy new telecardiology related services, particularly for atrial fibrillation patients that could be monitorized from several ambulatories.
- 1 March 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 7 (2) , 251-258
Comprehensive Geriatric Assessment and 2-Year Mortality in Elderly Patients Hospitalized for Heart Failure
Background—: In older adults hospitalized for heart failure, a poor score on a comprehensive geriatric assessment (CGA) is associated with worse prognosis during hospitalization and at 1 month after discharge. However, the association between the CGA score and long-term mortality is uncertain. Methods and Results—: This is a prospective study of 487 patients aged ≥75 years admitted for decompensated heart failure. At discharge, a CGA score (range, 0–10) was calculated based on limitation in activities of daily living, mobility limitation, comorbidity, cognitive decline, and previous medication use. The analysis of the association between the CGA score and 2-year subsequent mortality was performed with Cox regression and adjusted for the main confounders. A 1-point increase in the CGA score was associated with a 19% higher mortality (hazard ratio, 1.19; 95% confidence interval, 1.11–1.27). Results were similar regardless of age, sex, left ventricular ejection fraction, and the coexistence of atrial fibrillation, ischemic heart disease, or hypertensive cardiopathy. All components of the CGA score showed a consistent association with higher death risk: the hazard ratio (95% confidence interval) of mortality was 1.78 (1.25–2.54) with ≥3 versus 0 limitations in activities of daily living, 1.36 (1.0–1.86) with moderate or severe versus no or mild limitation in mobility, 1.98 (1.29–3.03) with a ≥5 versus ≤1 score on the Charlson index, 2.48 (1.84–3.34) with previous cognitive decline, and 1.77 (0.99–3.18) in those using ≥8 versus ≤3 medications. Conclusions—: The score on a simple CGA is associated with long-term mortality in older patients hospitalized for heart failure.
- 1 March 2014
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 7 (2) , 251-258
Comprehensive Geriatric Assessment and 2-Year Mortality in Elderly Patients Hospitalized for Heart Failure
Background—: In older adults hospitalized for heart failure, a poor score on a comprehensive geriatric assessment (CGA) is associated with worse prognosis during hospitalization and at 1 month after discharge. However, the association between the CGA score and long-term mortality is uncertain. Methods and Results—: This is a prospective study of 487 patients aged ≥75 years admitted for decompensated heart failure. At discharge, a CGA score (range, 0–10) was calculated based on limitation in activities of daily living, mobility limitation, comorbidity, cognitive decline, and previous medication use. The analysis of the association between the CGA score and 2-year subsequent mortality was performed with Cox regression and adjusted for the main confounders. A 1-point increase in the CGA score was associated with a 19% higher mortality (hazard ratio, 1.19; 95% confidence interval, 1.11–1.27). Results were similar regardless of age, sex, left ventricular ejection fraction, and the coexistence of atrial fibrillation, ischemic heart disease, or hypertensive cardiopathy. All components of the CGA score showed a consistent association with higher death risk: the hazard ratio (95% confidence interval) of mortality was 1.78 (1.25–2.54) with ≥3 versus 0 limitations in activities of daily living, 1.36 (1.0–1.86) with moderate or severe versus no or mild limitation in mobility, 1.98 (1.29–3.03) with a ≥5 versus ≤1 score on the Charlson index, 2.48 (1.84–3.34) with previous cognitive decline, and 1.77 (0.99–3.18) in those using ≥8 versus ≤3 medications. Conclusions—: The score on a simple CGA is associated with long-term mortality in older patients hospitalized for heart failure.
- 1 November 2012
- Published by Elsevier in American Heart Journal
- Vol. 164 (5) , 756-762
Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure
- 1 November 2012
- Published by Elsevier in American Heart Journal
- Vol. 164 (5) , 756-762
Comprehensive geriatric assessment and hospital mortality among older adults with decompensated heart failure